Advertisement
Advertisement

PPCB

PPCB logo

Propanc Biopharma, Inc. Common Stock

1.15
USD
Sponsored
-0.05
-4.17%
Aug 10, 15:54 UTC -4
Closed
exchange

After-Market

1.13

-0.02
-2.17%

Propanc Biopharma, Inc. Common Stock Profile

About

Propanc Biopharma, Inc. is a healthcare company. It focuses on the development of cancer treatments for pancreatic, ovarian and colorectal cancer primarily in Australia. The Company's products include PRP and PRP-DCM. Propanc Biopharma, Inc., formerly known as Propanc Health Group Corporation, is based in Camberwell, Australia.

Info & Links

CEO

James Nathanielsz

Headquarters

302, 6 Butler Street
Camberwell, C3 3124, AUSTRALIA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.propanc.com

Auditor

Salberg & Company, P.A.

Share holders

103

Employees

2

Propanc Biopharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

2.56M

Enterprise Value

2.64M

Enterprise Value/EBITDA(ttm)

-0.14

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.11

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-151.28%

Return on Invested Capital(ttm)

-157.04%

Return on Assets(ttm)

-109.53%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-18.37M

Net Income Available to Common(ttm)

-19.29M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

3.52

52-Week Change

--

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

2.28M

Dividend Yield

0.00%

Float4

1.63M

% Held by Insiders

28.50%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

443.70K

Total Cash Per Share(mrq)

0.19

Total Debt(mrq)

520.30K

Total Debt/Equity(mrq)

5.29%

Current Ratio(mrq)

2.37%

Quick Ratio(mrq)

2.37%

Book Value Per Share(mrq)

11.24

Cash Flow

Operating Cash Flow Per Share(ytd)

-4.55

Free Cash Flow(ytd)

-4.09M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement